A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Sana Biotechnology manoeuvres from Harvard Sana has emerged with funding from investors including F-Prime Capital, Arch and Flagship Pioneering to develop genetically modified hypoimmogenic stem cells. Strathclyde fuels industrial biotech proposal An industrial biotech initiative co-led by University of Strathclyde has received UK government funding to prepare an application to the UKRI’s competitive Strength in…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
